bioAffinity and Pictor Partner on Asthma and COPD Diagnostics

bioAffinity Technologies Inc. is working with Pictor Inc. to develop and commercialize bioAffinity’s next-generation diagnostic tests for asthma and chronic obstructive pulmonary disease. Medical Product Outsourcing reported the partnership, identifying asthma and COPD as the diagnostic focus of the companies’ work.

Partnership focuses on asthma and COPD diagnostics

The reported arrangement brings bioAffinity Technologies and Pictor together around bioAffinity’s next-generation diagnostic tests. According to Medical Product Outsourcing, the companies will work on both development and commercialization of those tests.

Asthma and COPD are the respiratory conditions named in the report. Medical Product Outsourcing described the collaboration as a partnership on diagnostics for those conditions, rather than as a general laboratory testing initiative.

The announcement identifies bioAffinity as the company behind the next-generation diagnostic tests and Pictor as its partner in the development and commercialization effort. No further product details, timelines, or commercial terms were included in the supplied report.

Development and commercialization are both included

Medical Product Outsourcing said the companies are working to develop and commercialize the diagnostic tests. The two stated activities place the partnership across test development and the path toward commercialization.

For medical and laboratory sales professionals following respiratory diagnostics, the reported event is a company partnership centered on bioAffinity’s tests for asthma and COPD. The available announcement names the companies, the diagnostic areas, and the intended development and commercialization work.

Key details from the announcement

• bioAffinity Technologies Inc. is working with Pictor Inc.
• The work concerns bioAffinity’s next-generation diagnostic tests.
• Asthma and COPD are the stated diagnostic focus.
• The companies intend to develop and commercialize the tests.

Medical Product Outsourcing reported the partnership announcement.